Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herceptin plus Carboplatin-Paclitaxel in Early Relapse HER2+ Ovarian Cancer
NCT00189579Phase 2Terminated
- Sponsor
- ARCAGY
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in ovarian cancer, sponsored by ARCAGY. Status: terminated.
02
Drugs
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00189579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189579.